Pre­ci­sion di­ag­nos­tics biotech wins newest round of in­vestor back­ing in bid to fa­cil­i­tate com­pa­ny ex­pan­sion

Di­ag­nos­tics firm Bil­lion­ToOne raised $55 mil­lion in a Se­ries B last year in a bid to ex­pand the com­pa­ny, which mar­kets a pre­na­tal screen­ing test. Nine months lat­er, thanks to some more in­vestors, the com­pa­ny of­fi­cial­ly has more mon­ey in its war chest to work with.

The Cal­i­for­nia di­ag­nos­tics com­pa­ny an­nounced an over­sub­scribed Se­ries C ear­ly this morn­ing, net­ting $125 mil­lion in its largest raise to date. That raise comes from a range of in­vestors, co-led by Adams Street Part­ners and Hum­ming­bird Ven­tures. A few oth­er in­vestors in­clude Nor­west Ven­ture Part­ners, Fifty Years VC and Lib­er­tus Cap­i­tal.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER